Up-regulation of the PI3K/AKT and RHO/RAC/PAK signalling pathways in CHK1 inhibitor resistant Eµ-Myc lymphoma cells. (2022)
Attributed to:
Advanced MS instrumentation for enhanced proteomics capabilities
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1042/bcj20220103
PubMed Identifier: 36240067
Publication URI: http://europepmc.org/abstract/MED/36240067
Type: Journal Article/Review
Volume: 479
Parent Publication: The Biochemical journal
Issue: 19
ISSN: 0264-6021